Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating how guanfacine affects drinking behavior in adults with alcohol use disorder (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use | Phase 2 | Status: RECRUITING